Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study (006)
Year: 2023
Type: article
Source: Gynecologic Oncology
Institutions: Memorial Sloan Kettering Cancer Center, NRG Oncology, Augusta University, University of Oklahoma Health Sciences Center, Adaptive Biotechnologies (United States), University of Pittsburgh Medical Center, National Institutes of Health, National Cancer Institute, Thomas Jefferson University, University of California San Diego
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4386948627
